Company Name, Ticker, Suppliers, else..

Amneal Pharmaceuticals Inc (AMRX)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Amneal Pharmaceuticals Inc

AMRX's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

AMRX Growth rates comparisons

Looking into Amneal Pharmaceuticals Inc growth rates, revenue grew by 3.22 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 1450

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.56 %

Amneal Pharmaceuticals Inc net loss deacreased by in III. Quarter 2022 year on year, Amneal Pharmaceuticals Inc net loss increased by -60.77 % in III. Quarter 2022 year on year,

• More on AMRX's Growth

AMRX's Valuation comparisons

Amneal Pharmaceuticals Inc
realized net loss in trailing twelve months.

Amneal Pharmaceuticals Inc realized cash outflow of $ -1.42per share in trailing twelve-month period.

Company

-

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 0.1.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.65.

• More on AMRX's Valuation

Total Debt (Millions $)	2,637
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	3.35
Tangible Book Value (Per Share $)	-10.33

AMRX's Valuation comparisons

Amneal Pharmaceuticals Inc
realized net loss in trailing twelve months.

Amneal Pharmaceuticals Inc realized cash outflow of $ -1.42per share in trailing twelve-month period.

Company

-

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 0.1.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.65.

Amneal Pharmaceuticals Inc Price to Book Ratio is at 1.08 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

• More on AMRX's Valuation

• Market Capitalization (Millions $)	210
• Shares Outstanding (Millions)	151
• Employees	-
• Revenues (TTM) (Millions $)	2,112
• Net Income (TTM) (Millions $)	-269
• Cash Flow (TTM) (Millions $)	-215
• Capital Exp. (TTM) (Millions $)	-95
• Total Debt (Millions $)	2,637
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	3.35
• Tangible Book Value (Per Share $)	-10.33

• Market Capitalization (Millions $)	210
• Shares Outstanding (Millions)	151
• Employees	-
• Revenues (TTM) (Millions $)	2,112
• Net Income (TTM) (Millions $)	-269
• Cash Flow (TTM) (Millions $)	-215
• Capital Exp. (TTM) (Millions $)	-95

AMRX's Profitability Comparisons
Amneal Pharmaceuticals Inc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2022 to 8.14 %.

	*Ratio*
• Capital Ratio (MRQ)	1.74
• Total Debt to Equity (MRQ)	13.57
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.54
• Inventory Turnover Ratio (TTM)	2.65

AMRX's Profitability Comparisons

Amneal Pharmaceuticals Inc achieved increase in profitability, due to cost control. Operating Margin grew in III. Quarter 2022 to 8.14 %.

• More on AMRX's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar UNB's Profile Stock Price UNB's Financials Business Description Fundamentals Charts & Quotes UNB's News Suppliers UNB's Competitors Customers & Markets Economic Indicators UNB's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071